Evidence map›Paper›PMID 36539739›Full record

ArticleBMC cancer2022

Self-assembled DNA nanostructure containing oncogenic miRNA-mediated cell proliferation by downregulation of FOXO1 expression.

Avishek Kar, Kanchan Kumari, Sandip K Mishra, Umakanta Subudhi

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Avishek KarDNA Nanotechnology and Application Laboratory, CSIR-Institute of Minerals and Materials Technology, 751013, Bhubaneswar, India.
Kanchan KumariDNA Nanotechnology and Application Laboratory, CSIR-Institute of Minerals and Materials Technology, 751013, Bhubaneswar, India.
Sandip K MishraCancer Biology Laboratory, Institute of Life Sciences, 751023, Bhubaneswar, India.
Umakanta SubudhiDNA Nanotechnology and Application Laboratory, CSIR-Institute of Minerals and Materials Technology, 751013, Bhubaneswar, India. usubudhi@immt.res.in.
Institute of Minerals and Materials Technology · INInstitute of Life Sciences · IN

Funding

Council of Scientific and Industrial Research, India YSP-05Department of Biotechnology, Ministry of Science and Technology, India GAP-312
6 · The paper itself

Abstract

FOXO1 transcription factor not only limits the cell cycle progression but also promotes cell death as a tumor suppressor protein. Though the expression of FOXO1 is largely examined in breast cancer, the regulation of FOXO1 by miRNA is yet to be explored. In the current study, self-assembled branched DNA (bDNA) nanostructures containing oncogenic miRNAs were designed and transfected to the MCF7 cell line to decipher the FOXO1 expression. bDNA containing oncogenic miRNAs 27a, 96, and 182 synergistically downregulate the expression of FOXO1 in MCF7 cells. The down-regulation is evident both in mRNA and protein levels suggesting that bDNA having miRNA sequences can selectively bind to mRNA and inhibit translation. Secondly, the downstream gene expression of p21 and p27 was also significantly downregulated in presence of miR-bDNA nanostructures. The cell proliferation activity was progressively increased in presence of miR-bDNA nanostructures which confirms the reduced tumor suppression activity of FOXO1 and the downstream gene expression. This finding can be explored to design novel bDNA structures which can downregulate the tumor suppressor proteins in normal cells and induce cell proliferation activity to identify early-phase markers of cancer.

Indexed as

MicroRNAsCell Line, TumorCell ProliferationDNADown-RegulationForkhead Box Protein O1Gene Expression Regulation, NeoplasticHumansRNA, MessengerDNAForkhead Box Protein O1FOXO1 protein, humanMicroRNAsRNA, MessengerBreast cancerDNA nanostructureFOXO1MCF7 cell linemiRNAsP21P27

Identifiers

PMID36539739
PMCPMC9764560
OpenAlexW4312114076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.